Abbott introduces Libre Sense Glucose Sport Biosensor in Europe, world's first glucose biosensor designed for athletes
Abbott is collaborating with sports performance technology company Supersapiens to advance this first-of-its-kind product
Abbott is collaborating with sports performance technology company Supersapiens to advance this first-of-its-kind product
Join us on Monday, September 28, for this expert-led webinar on the intricacies of Raman technology
The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity
A comprehensive and interactive digital guide, to real-time live-cell imaging and analysis
These findings could lead to new preventative strategies, including diet and lifestyle interventions
Virus-fighting viperins, part of the human immune system, turn out to have bacterial counterparts that might boost the fight against human disease
Access Anti-SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, aims to provide accurate results in less than 15 minutes
Sebastian Peck discusses an automated high-content imaging solution designed to deliver more precise results from complex biological assays
SelectScience goes behind the scenes to meet some of the key people driving the microplate reader innovator
Watch this on-demand webinar to learn strategies for sample preparation, instrument method development and optimization, plus workflow applicability to their practical applications
Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis
New dye offers researchers improved brightness to resolve rare and low antigen density populations more easily
Join us on Thursday, September 24, to learn more about new updates of the NanoDrop One platform
RiboShield RNase Inhibitor complements PCR Biosystems’s range of products to support COVID-19 research and testing
Join us to gain an overview of recent technological advances in CRISPR/Cas gene editing
The study has uncovered a genetic vulnerability present in nearly 10% percent of all breast cancers tumors
The award money will help to expand Nanotrap Particle manufacturing capacity for COVID-19 testing
Leinco Technologies has launched the COVID-19 ImmunoRank Neutralization ELISA Test Kit